Aditxt Inc ADTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
3.25quote price arrow down-0.15 (-4.41%)
Volume
179,946
Close
3.40quote price arrow up+0.36 (+11.84%)
Volume
185,765
52 week range
2.95 - 76.40
Loading...
  • Open3.05
  • Day High3.49
  • Day Low3.05
  • Prev Close3.04
  • 52 Week High76.40
  • 52 Week High Date04/20/23
  • 52 Week Low2.95
  • 52 Week Low Date03/27/24

Key Stats

  • Market Cap1.502M
  • Shares Out441,850.01
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change-48.72

KEY STATS

  • Open3.05
  • Day High3.49
  • Day Low3.05
  • Prev Close3.04
  • 52 Week High76.40
  • 52 Week High Date04/20/23
  • 52 Week Low2.95
  • 52 Week Low Date03/27/24
  • Market Cap1.502M
  • Shares Out441,850.01
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change-48.72

RATIOS/PROFITABILITY

  • EPS (TTM)-215.57
  • P/E (TTM)-0.02
  • Fwd P/E (NTM)-0.09
  • EBITDA (TTM)-25.743M
  • ROE (TTM)-698.60%
  • Revenue (TTM)749,490.023
  • Gross Margin (TTM)14.46%
  • Net Margin (TTM)-3,948.79%
  • Debt To Equity (MRQ)-98.73%

EVENTS

  • Earnings Date03/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aditxt Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious...
Amro Albanna
Chairman of the Board, Chief Executive Officer
Rowena Albanna
Chief Operating Officer
Thomas Farley
Chief Financial Officer
Address
737 N. Fifth Street, Suite 200
Richmond, VA
23219
United States